Literature DB >> 25892496

How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics.

Pasquale Patrizio1, Alberto Vaiarelli2, Paolo E Levi Setti3, Kyle J Tobler4, Gon Shoham5, Milton Leong6, Zeev Shoham7.   

Abstract

Poor responders represent a significant percentage of couples treated in IVF units (10-24%), but the standard definition of poor responders remains uncertain and consequently optimal treatment options remain subjective and not evidence-based. In an attempt to provide uniformity on the definition, diagnosis and treatment of poor responders, a worldwide survey was conducted asking IVF professionals a set of questions on this complex topic. The survey was posted on www.IVF-worldwide.com, the largest and most comprehensive IVF-focused website for physicians and embryologists. A total of 196 centres replied, forming a panel of IVF units with a median of 400 cycles per year. The present study shows that the definition of poor responders is still subjective, and many practices do not use evidence-based treatment for this category of patients. Our hope is that by leveraging the great potential of the internet, future studies may provide immediate large-scale sampling to standardize both poor responder definition and treatment options.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IVF; decreased ovarian function; management; ovarian stimulation; poor responder; survey

Mesh:

Year:  2015        PMID: 25892496     DOI: 10.1016/j.rbmo.2015.03.002

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  34 in total

1.  Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum levels and progesterone assay interference that may impact clinical management in IVF.

Authors:  Jason M Franasiak; Semara Thomas; Susan Ng; Maria Fano; Andrew Ruiz; Richard T Scott; Eric J Forman
Journal:  J Assist Reprod Genet       Date:  2016-01-12       Impact factor: 3.412

Review 2.  Efficacy of the delayed start antagonist protocol for controlled ovarian stimulation in Bologna poor ovarian responders: a systematic review and meta-analysis.

Authors:  Shuang Yang; Nenghui Liu; Yanping Li; Lei Zhang; Rongya Yue
Journal:  Arch Gynecol Obstet       Date:  2020-11-24       Impact factor: 2.344

Review 3.  Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials.

Authors:  Marco Noventa; Amerigo Vitagliano; Alessandra Andrisani; Mija Blaganje; Paola Viganò; Enrico Papaelo; Marco Scioscia; Francesco Cavallin; Guido Ambrosini; Mauro Cozzolino
Journal:  J Assist Reprod Genet       Date:  2019-01-05       Impact factor: 3.412

4.  Blastocyst versus cleavage transfers: who benefits?

Authors:  Enver Kerem Dirican; Safak Olgan; Mehmet Sakinci; Mete Caglar
Journal:  Arch Gynecol Obstet       Date:  2021-09-06       Impact factor: 2.344

Review 5.  Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.

Authors:  Meixiang Zhang; Wenbin Niu; Yu Wang; Jiawei Xu; Xiao Bao; Linlin Wang; Linqing Du; Yingpu Sun
Journal:  J Assist Reprod Genet       Date:  2016-04-19       Impact factor: 3.412

6.  Dehydroepiandrosterone (DHEA) supplementation: an underappreciated cause of premature progesterone elevation detected during frozen embryo transfer.

Authors:  Frank Shao-Ying Wu; Shao-Ping Weng; Meng-Shun Shen
Journal:  J Assist Reprod Genet       Date:  2018-01-18       Impact factor: 3.412

7.  Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial.

Authors:  Li Shu; Qianhua Xu; Qingxia Meng; Xue Dai; Yun Zhang; Wei Zhou; Honggang Yi; Jinyong Liu; Chunxiang Wu; Zhen Hou; Yugui Cui; Tin Chiu Li; Jiayin Liu
Journal:  Ann Transl Med       Date:  2019-04

Review 8.  Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.

Authors:  Amarin Narkwichean; Walid Maalouf; Bruce K Campbell; Kannamannadiar Jayaprakasan
Journal:  Reprod Biol Endocrinol       Date:  2013-05-16       Impact factor: 5.211

9.  The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jing-Yan Song; Dan-Dan Gao; Xian-Ling Cao; Shan Xiang; Yan-Hua Chen; Yi-Li Teng; Xiu-Fang Li; Hai-Ping Liu; Fu-Xin Wang; Bin Zhang; Li-Hua Xu; Li Zhou; Xiang-Hong Huang; Zhen-Gao Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

10.  Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.

Authors:  Shaodi Zhang; Yisha Yin; Qiuyuan Li; Cuilian Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.